Page last updated: 2024-08-22

n-methylaspartate and CJD (Creutzfeldt-Jakob Disease)

n-methylaspartate has been researched along with CJD (Creutzfeldt-Jakob Disease) in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertani, I; Chiesa, R; Foray, C; Iori, V; Mantovani, S; Maroso, M; Tonini, R; Trusel, M; Vezzani, A1

Other Studies

1 other study(ies) available for n-methylaspartate and CJD (Creutzfeldt-Jakob Disease)

ArticleYear
Inhibition of IL-1β Signaling Normalizes NMDA-Dependent Neurotransmission and Reduces Seizure Susceptibility in a Mouse Model of Creutzfeldt-Jakob Disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017, 10-25, Volume: 37, Issue:43

    Topics: Animals; Creutzfeldt-Jakob Syndrome; Disease Models, Animal; Disease Susceptibility; Female; Hippocampus; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; N-Methylaspartate; Neuronal Plasticity; Random Allocation; Receptors, N-Methyl-D-Aspartate; Seizures; Signal Transduction; Synaptic Transmission

2017